ArticleThe Journal of biological chemistry2013

An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in mice.

François Daubeuf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.